CC0 + carboplatin + paclitaxel

CC0 + carboplatin + paclitaxel is a combination chemotherapy regimen consisting of three agents. While "carboplatin" and "paclitaxel" are well-established cytotoxic chemotherapeutic drugs commonly used together to treat various solid tumors such as ovarian, lung, endometrial, and cervical cancers[1][3][4], the component "CC0" is not recognized as a standard drug or code name in oncology or pharmacology databases. The mechanism of action for this regimen would be determined by its components: - Carboplatin is a platinum-based compound that causes DNA crosslinking and apoptosis in rapidly dividing cells. - Paclitaxel stabilizes microtubules and inhibits cell division by preventing depolymerization during mitosis. The addition of "CC0" may refer to an investigational agent or protocol-specific identifier; however, no publicly available information clarifies its identity.

Other names

CC0 plus carboplatin plus paclitaxelCC-0 plus carboplatin plus paclitaxelCC 0 plus carboplatin plus paclitaxelCC0/carboplatin/paclitaxel combination